by Genevieve McLachlan | Jan 17, 2018 | Events, Medical Condition, Research, Retina NZ, Visual Impairment
Why is marketing approval for the first retinal gene therapy treatment for patients with blinding retinal degenerations so significant? Is there an exciting future for applying stem cell therapy to treating retinal disorders and what are the scientific and ethical...
by Genevieve McLachlan | Dec 13, 2017 | Accessibility, Events, Medical Condition, Research, Retina NZ, Visual Impairment
The countdown has begun! Retina 2018 New Zealand, hosted at the University of Auckland, February 10-11, 2018 will offer patients and their families, clinicians, rehabilitation professionals, scientists, students and anyone with an interest in retinal disorders with...
by Genevieve McLachlan | Oct 16, 2017 | Events, Research, Retina NZ, Visual Impairment
Retina 2018 New Zealand to be held at the University of Auckland, February 10-11, 2018 will offer patients and their families, clinicians, rehabilitation professionals, scientists, students and anyone with an interest in retinal disorders with interactive learning and...
by Genevieve McLachlan | Aug 11, 2017 | Education, Events, Health Services, Medical Condition, Retina NZ, Visual Impairment
Retina 2018 New Zealand will offer patients and their families, clinicians, rehabilitation professionals, students and anyone with an interest in retinal disorders with interactive learning and networking opportunities that include short scientific presentations,...
by Genevieve McLachlan | May 26, 2017 | Accessibility, Education, Retina NZ
A MANIFESTO Elderly and disabled people are taking over your country. The number of Kiwis aged 65+ is escalating. Disabilities increase with age. Almost 60% of seniors have a disability. That figure is bound to escalate too. Here’s the good news: we seniors know that...
by Genevieve McLachlan | May 24, 2017 | Events, Newsletter, NZ Disability Strategy, Retina NZ
Read what we’ve been up to in our May newsletter. Please feel free to share this and if you’d like a copy sent directly to your in-box, you can subscribe on our web site.
